Literature DB >> 3511807

Occurrence of the adult respiratory distress syndrome in neutropenic patients.

R J Maunder, R C Hackman, E Riff, R K Albert, S C Springmeyer.   

Abstract

Neutrophils are believed to play an essential role in the pathogenesis of the adult respiratory distress syndrome (ARDS). This concept is largely based on the observation that neutrophil depletion protects against altered pulmonary vascular permeability in several models of acute lung injury produced in laboratory animals. Four patients who developed ARDS during periods of profound neutropenia are presented. These patients met commonly accepted clinical and roentgenographic criteria for the syndrome, and each had the characteristic findings of diffuse alveolar damage by lung histologic examination. The failure of this degree of neutropenia to protect against ARDS in humans raises questions about whether neutrophils or neutrophil products are essential in the pathogenesis of the syndrome.

Entities:  

Mesh:

Year:  1986        PMID: 3511807     DOI: 10.1164/arrd.1986.133.2.313

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

Review 1.  The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatment.

Authors:  M A Matthay
Journal:  West J Med       Date:  1989-02

2.  Role of E-selectin in bleomycin induced lung fibrosis in mice.

Authors:  A Azuma; S Takahashi; M Nose; K Araki; M Araki; T Takahashi; M Hirose; H Kawashima; M Miyasaka; S Kudoh
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Ex vivo lung perfusion as a human platform for preclinical small molecule testing.

Authors:  Nathaniel M Weathington; Diana Álvarez; John Sembrat; Josiah Radder; Nayra Cárdenes; Kentaro Noda; Qiaoke Gong; Hesper Wong; Jay Kolls; Jonathan D'Cunha; Rama K Mallampalli; Bill B Chen; Mauricio Rojas
Journal:  JCI Insight       Date:  2018-10-04

4.  Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury.

Authors:  William Bain; Tolani Olonisakin; Minting Yu; Yanyan Qu; Mei Hulver; Zeyu Xiong; Huihua Li; Joseph Pilewski; Rama K Mallampalli; Mehdi Nouraie; Anuradha Ray; Prabir Ray; Zhenyu Cheng; Robert M Q Shanks; Claudette St Croix; Roy L Silverstein; Janet S Lee
Journal:  Blood Adv       Date:  2019-02-12

Review 5.  The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung Injury.

Authors:  Johan Rebetz; John W Semple; Rick Kapur
Journal:  Transfus Med Hemother       Date:  2018-09-21       Impact factor: 3.747

6.  Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice.

Authors:  E Wang; N Ouellet; M Simard; I Fillion; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta.

Authors:  S E Goldblum; K Yoneda; D A Cohen; C J McClain
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Surfactant-associated protein B is critical to survival in nickel-induced injury in mice.

Authors:  Kiflai Bein; Scott C Wesselkamper; Xiangdong Liu; Maggie Dietsch; Nilanjana Majumder; Vincent J Concel; Mario Medvedovic; Maureen A Sartor; Lisa N Henning; Carmen Venditto; Michael T Borchers; Aaron Barchowsky; Timothy E Weaver; Jay W Tichelaar; Daniel R Prows; Thomas R Korfhagen; William D Hardie; Cindy J Bachurski; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-08       Impact factor: 6.914

9.  Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice.

Authors:  Erjian Wang; Marie Simard; Nathalie Ouellet; Yves Bergeron; Denis Beauchamp; Michel G Bergeron
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 10.  Neutrophil-mediated tissue injury and its modulation.

Authors:  S Fujishima; N Aikawa
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.